Stanford, CA4 Active Studies

Advanced Solid Tumors Clinical Trials in Stanford, CA

Find 4 actively recruiting advanced solid tumors clinical trials in Stanford, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
407
Enrolling

Recruiting Advanced Solid Tumors Studies in Stanford

RecruitingStanford, CANCT06051695

A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

The goal of this study is to test A2B694, an autologous logic-gated Tmodâ„¢ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), pancreatic cancer (PANC), non-small cell l...

230 participants
A2 Biotherapeutics Inc.
View Study Details
RecruitingStanford, CANCT06234098

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

This is a first-in-human, multicenter, open-label, dose escalation and dose expansion Phase 1/2 study to determine the MTD and/or the recommended Phase 2 dose (RP2D) and to characterize DLTs of AT-196...

85 participants
Alyssum Therapeutics
View Study Details
RecruitingStanford, CANCT06060613

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

This is a study to investigate the safety and efficacy of an investigational OBX-115 regimen in adult participants with advanced solid tumors....

52 participants
Obsidian Therapeutics, Inc.
View Study Details
RecruitingStanford, CANCT04260256

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

In this study, patients with advanced solid tumors will undergo \[18F\]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT....

40 participants
CellSight Technologies, Inc.
View Study Details

About Advanced Solid Tumors Clinical Trials in Stanford

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 4 advanced solid tumors clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 407 participants. Research is being sponsored by A2 Biotherapeutics Inc., Alyssum Therapeutics, Obsidian Therapeutics, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Stanford — FAQ

Are there advanced solid tumors clinical trials in Stanford?

Yes, there are 4 advanced solid tumors clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 4 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov